ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma

Chen, Zerong; Huang, Zehai; Hui, Jialiang; Chen, Zhuangfei; Zhang, Haibo; Jiang, Yaodong*; Zeng, Weisen*南方医科大学
Journal of Oncology2022-9-29DOI: 10.1155/2022/7495183
2被引6阅读
引用收藏
分享

摘要

Background. Kidney renal clear cell carcinoma (KIRC) lacks effective prognostic biomarkers and the role and mechanism of N6-methyladenosine (m6A) modification of long noncoding RNAs (lncRNAs) in KIRC remain unclear. Methods. We extracted standard mRNA-sequencing and clinical data from the TCGA database. The prognostic risk model was obtained by Lasso regression and Cox regression. We randomly divided the samples into training and test sets, each taking half of the cases. Based on Lasso regression and Cox regression for training set, the prognostic risk signature was constructed; risk scores were calculated with the R package "glmnet. " Based on the median value of the prognostic risk score, risk scores were calculated for each patient and we divided all KIRC samples into high-risk and low-risk groups. Then, high- and low-risk subtypes were established and their prognosis, clinical features, and immune infiltration microenvironment were evaluated in test set and the entire sampled data set. The reliability of the prognostic model was confirmed by receiver operating characteristic curve analysis. Results. We found 28 prognostic m6A-related lncRNAs and established a m6A-related lncRNAs prognostic signature. Risk score=AC015813.1*0.0086+EMX2OS*-0.0101+LINC00173*0.0309+PWAR5*-0.0146+SNHG1*0.0043. The signature showed a better predictive ability than other clinical indicators, including tumor node metastasis classification (TNM), histological, and pathological stages. In the high-risk group, M0 macrophages, CD8+ T cells, and regulatory T cells had significantly higher scores. Contrarily, in the low-risk group, activated dendritic cells, M1 macrophages, mast resting cells, and monocytes had significantly higher scores. In the high-risk group, LSECtin was overexpressed. In the low-risk group, PD-L1 was overexpressed. Moreover, high-risk patients may benefit more from AZ628. Conclusions. In conclusion, prognosis prediction of patients with KIRC and new insights for immunotherapy are provided by the m6A-related lncRNA prognostic signature.

学科与关键词

关键词
LONG NONCODING RNACANCER CELLSPROGRESSIONPROLIFERATIONMETASTASISSUNITINIBSURVIVALTHERAPYMETTL14ROLES
相关
加载中…
  • The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma
    Zhang, Wei; Liu, Zhiming; Wang, Jinpeng; Geng, Bo; Hou, Wenbin; Zhao, Enyang*; Li, Xuedong*Frontiers in Immunology, 2022, 13: 934387.被引 3
  • A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma
    Zhang, Zedan; Tang, Yanlin; Liu, Yanjun; Zhuang, Hongkai; Lin, Enyu; Xie, Lu; Feng, Xiaoqiang; Tian, Kaiwen; Zeng, Jiayi; Liu, Jiumin; Yu, Yuming*Journal of Immunology Research, 2021, 2021: 9921466.被引 10
  • N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma
    Ming, Jie; Wang, Chunyang*Frontiers in Genetics, 2022, 13: 871899.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-09-29
卷期
第 2022 卷
页码
7495183
DOI
10.1155/2022/7495183
期刊等级
4区
成果收录
SCIE
资助标注
President Foundation of Nanfang Hospital, Southern Medical University; [2018C007]

作者

  • C

    Chen, Zerong (第一作者)

    southern med univ

  • H

    Huang, Zehai

    southern med univ

查看全部 7 位作者收起作者
  • H

    Hui, Jialiang

    southern med univ

  • C

    Chen, Zhuangfei

    southern med univ

  • Z

    Zhang, Haibo

    southern med univ

  • J

    Jiang, Yaodong (通讯)

    southern med univ

  • Z

    Zeng, Weisen (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417